ECDC and the European AIDS Clinical Society (EACS) recently worked together to acquire knowledge on the occurrence of HIV-related stigma and discrimination among people working in various healthcare settings in Europe and Central Asia. A survey was developed by a multi-stakeholder group, based on an existing questionnaire.
This is an external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility established in 2007 as part of the European Surveillance to STIs programme.
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
An EQA scheme for antimicrobial susceptibility testing in Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This is the third EQA to be published on antimicrobial susceptibility testing in Neisseria gonorrhoeae.
This report provides an analysis of the EQA performance of laboratories in the 28 EU/EEA countries in relation to the detection/isolation, identification, enumeration and quantification of Legionella spp. and the further characterisation of L. pneumophila, by serogrouping and sequence-based typing, from both clinical and environmental samples, where applicable.
In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This report presents the result of the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008.
In September/October 2013, the European Reference Laboratory Network for Human Influenza (ERLI-Net) conducted an external quality assessment (EQA) for the rapid detection of influenza virus, its isolation and culture.